Wymzya Fe
Product Images NDC 68180-898

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Wymzya Fe (NDC 68180-898). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Norethindrone Structural Formula (F9cfdf35 7cd0 4984 99e4 0e4a7df91b4e 01)

Chemical structure diagram showing a steroid-like molecular framework with a ketone group (O) and hydroxyl group (OH), a methyl group (CH3), and an ethynyl group (C≡CH). This represents the active ingredient structure associated with the WYMZYA FE product by Lupin Pharmaceuticals.*

FDA Label Image

Ethinyl Estradiol Structural Formula (F9cfdf35 7cd0 4984 99e4 0e4a7df91b4e 02)

Chemical structure diagram depicting the molecular composition of the active ingredient in WYMZYA FE by Lupin Pharmaceuticals, Inc. The diagram shows a multi-ring steroid structure with hydroxyl groups and an alkyne functional group, indicating the specific chemical arrangement of the drug's active molecule.*

FDA Label Image

Figure 1 Circulatory Disease Mortality Rates Per 100,000 Women-years By Age, Smoking Status And Oral Contraceptive Use (F9cfdf35 7cd0 4984 99e4 0e4a7df91b4e 03)

A bar graph titled 'Figure 1' showing circulatory disease mortality rates per 100,000 women-years by age group, smoking status, and oral contraceptive use. The x-axis represents age groups (15-24, 25-34, 35-44, 45+), and the y-axis represents mortality rate. Four categories are displayed with different bar colors: ever-users nonsmokers, ever-users smokers, controls nonsmokers, and controls smokers.*

FDA Label Image

Pill Pack Image (F9cfdf35 7cd0 4984 99e4 0e4a7df91b4e 04)

WYMZYA FE chewable and ferrous fumarate tablets label from Lupin Pharmaceuticals, Inc. It shows a 4-week dosing calendar with circles for days Sunday through Saturday across four rows labeled Week 1 (active), Week 2 (active), Week 3 (active), and Week 4 (inactive). Each circle corresponds to a daily tablet dose.*

FDA Label Image

Pill Pack Image (F9cfdf35 7cd0 4984 99e4 0e4a7df91b4e 05)

WYMZYA FE chewable tablets packaging label from Lupin Pharmaceuticals, Inc., showing a weekly oral contraceptive schedule. The label indicates active tablets for Weeks 1 to 3 and inactive tablets for Week 4, with daily dose circles arranged by day (Sun-Sat). Tablet strength is 0.4 mg norethindrone and 35 mcg ethinyl estradiol, plus ferrous fumarate.*

FDA Label Image

Lupin (F9cfdf35 7cd0 4984 99e4 0e4a7df91b4e 06)

FDA Label Image

Wymzya Fe (norethindrone And Ethinyl Estradiol Tablets, Chewable And Ferrous Fumarate Tablets) 0.4 mg/35 Mcg Label (F9cfdf35 7cd0 4984 99e4 0e4a7df91b4e 07)

Packaging label for WYMZYA FE chewable tablets containing norethindrone (0.4 mg) and ethinyl estradiol (35 mcg) with ferrous fumarate (75 mg). The label states a 28-day regimen with 5 blister cards, each containing 28 tablets. Manufactured for Lupin Pharmaceuticals, Inc., with distributor Warner Chilcott Company, LLC. The label features a pink to white gradient background with branding and dosage details.*

FDA Label Image

Wymzya Fe Trade Credit Card (F9cfdf35 7cd0 4984 99e4 0e4a7df91b4e 08)

WYMZYA FE oral tablet blister pack from Lupin Pharmaceuticals, Inc. The white round tablets are arranged in four rows by seven columns, labeled by days of the week in pink text starting with Sunday and ending with Saturday. The product name WYMZYA FE and the labeler Lupin Pharmaceuticals are printed on the blister along with dosage strength 0.4 mg/35 mcg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.